The three pharmaceutical giants that have in recent weeks said they’ll invest a total of $12.5 billion in new Virginia facilities are kicking in $120 million more to build a center for training the high-tech workers they will need.
The new Center for Advanced Pharmaceutical Manufacturing will be turning out graduates in two years time, said Gov. Glenn Youngkin. He announced a memorandum of understanding with AstraZeneca, Eli Lilly and Merck along with Virginia Commonwealth University, James Madison University, Hampton University, the University of Virginia, Virginia Tech and the Virginia Community College System.
Read the full story in the Richmond Times-Dispatch.
